CFTR and cystic fibrosis: The sensitivity of CF NBS programs utilizing a CFTR sequencing tier was generally >90% and comparable to some programs utilizing IRT-DNA; however, specificity and PPV were significantly improved by inclusion of sequencing, ranging from 99% to 100% and 34–77%, respectively [9,49,76,77].